Financials data is unavailable for this security.
View more
Year on year Puma Biotechnology Inc grew revenues 3.34% from 228.03m to 235.64m while net income improved 1,079,450.00% from 2.00k to 21.59m.
Gross margin | 73.08% |
---|---|
Net profit margin | 3.98% |
Operating margin | 8.63% |
Return on assets | 4.30% |
---|---|
Return on equity | 22.10% |
Return on investment | 7.24% |
More ▼
Cash flow in USDView more
In 2023, Puma Biotechnology Inc increased its cash reserves by 10.01%, or 7.88m. The company earned 27.01m from its operations for a Cash Flow Margin of 11.46%. In addition the company used 19.13m on investing activities while cash flow from financing was even.
Cash flow per share | 0.422 |
---|---|
Price/Cash flow per share | 6.19 |
Book value per share | 1.00 |
---|---|
Tangible book value per share | -0.1546 |
More ▼
Balance sheet in USDView more
Current ratio | 1.32 |
---|---|
Quick ratio | 1.23 |
Total debt/total equity | 1.84 |
---|---|
Total debt/total capital | 0.6474 |
More ▼